Evangelismos Medical Center

Hospital


Location: Athens, Greece (GR) GR

ISNI: -

Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial (2022) Terpos E, Dimopoulos MA, Boccadoro M, Delimpasi S, Beksac M, Katodritou E, Moreau P, et al. Journal article Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial (2021) Dimopoulos MA, Terpos E, Boccadoro M, Delimpasi S, Beksac M, Katodritou E, Moreau P, et al. Journal article HLA HAPLOTYPES IN 250 FAMILIES: A CORE NGS TESTING MODEL FOR THE 17TH INTERNATIONAL HLA AND IMMUNOGENETICS WORKSHOP (2019) Askar M, Madbouly A, Zhrebker L, Willis A, Kennedy S, Padros K, Rodriguez MB, et al. Conference contribution HLA HHaplotypes In 250 Families: The Baylor Laboratory Results And A Aerspective On A Core NGS Testing Model For The 17th International HLA And Immunogenetics Workshop (2019) Askar M, Madbouly A, Zhrebker L, Willis A, Kennedy S, Padros K, Rodriguez MB, et al. Journal article, Review article The histopathological approach to inflammatory bowel disease: A practice guide (2014) Langner C, Magro F, Driessen A, Ensari A, Mantzaris GJ, Villanacci V, Becheanu G, et al. Journal article, Review article European consensus on the histopathology of inflammatory bowel disease (2013) Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, Villanacci V, et al. Journal article